PRL-8-53

chemical compound

Uses your system voice; voice and rate in settings.

Q15409347Snapshot

≈ 1 min read

Names in other languages

  • EnglishPRL-8-53
  • EspañolPRL-8-53
  • РусскийPRL-8-53
  • shPRL-8-53
  • СрпскиPRL-8-53
  • 中文PRL-8-53

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.

Mechanism of action

The exact mechanism of action of PRL-8-53 remains unknown. Doses up to 200 mg/kg are not observed to have stimulant properties, and a dosage of 20 mg/kg does not potentiate the effects of dextroamphetamine in rats. It displays possible cholinergic properties, and potentiates dopamine while partially inhibiting serotonin. PRL-8-53 reverses the catatonic and ptotic effects of reserpine.

Toxicity

PRL-8-53 is relatively non-toxic, with an oral in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED 50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.

Synonyms

Methyl 3-(2-(benzylmethylamino)ethyl)benzoate hydrochloride 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride 3-(2-(Methyl(phenylmethyl)amino)ethyl)benzoic acid methyl ester hydrochloride

Text derived from https://en.wikipedia.org/w/index.php?oldid=1345291835 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.